Japan considers to begin administering 3rd shots of COVID-19 vaccine by year-end

2021-09-18 08:17:31Xinhua Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

Japan may begin administering the third shot of COVID-19 vaccines to people who are eligible by the end of this year, the health ministry said Friday.

Studies showed that COVID-19 antibodies would decrease six months after taking the second shot of the vaccine and vaccine efficacy against the Delta variant would become lower over time. In addition, vaccine makers said that since confirmed infections among fully vaccinated people were increasing in Japan and abroad, the booster shot would be necessary.

Health experts of a Japanese government subcommittee agreed on the necessity of the third shot and approved the ministry's plan to start inoculating people at least eight months after they received their second shot.

Based on Japan's vaccination progress, people may start receiving the booster shot from November, and the Japanese government will discuss the population eligible for the third shot and the order of priority based on data and the progress of other nations.

A subcommittee member said medical workers treating COVID-19 patients need to be allowed to receive their third shot as soon as possible, but another member thought people who have not received two shots and currently wanted the vaccine should be prioritized.

The Ministry of Health, Labor and Welfare said that in principle, all three doses should be from the same manufacturer. However, the ministry said that under certain situations, people could take the booster shot produced by a different company, giving the first two shots should be doses of the same supplier, and it would revise rules to enable that.

Japan currently provides COVID-19 vaccines developed by Pfizer Inc., Moderna Inc., and AstraZeneca Plc, and all types require receiving two doses.


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2021 All rights reserved.
Reproduction in whole or in part without permission is prohibited.